🌱GROW Seedrs Campaign
📫 Important Crowdfunding Update
Dear GROW Community Readers,Â
🚀 We are looking forward to bringing some exciting content to you this year and will be in touch with further updates regarding what GROW is up to and how we're working to deliver on our mission to get cannabis medicines to patients globally.Â
🤓 We would love to hear from you on what you'd like to learn more about in this nascent industry.
🙌 GROW is pleased to announce that we are reinstating EIS investor tax benefits. We have a limited remainder of our allocation, which will be offered to investors* on a first come, first served basis. Please contact us directly for more information.
📣 On Tuesday, we made an announcement regarding our Seedrs Campaign as part of a review of our fundraising strategy. As many of you joined us during our campaign, we would like to inform you that we have decided to move away from Seedrs and have released a statement from our CEO, Ben Langley, regarding the close. We will continue to raise funds directly, as highlighted below.
For any questions please do not hesitate to contact Hannah Nommé directly at hannah.nomme@growbiotech.com.
🌱 GROW Seedrs CampaignÂ
📫 Important Crowdfunding UpdateÂ
Dear GROW Community,Â
I want to personally thank you for your continued interest in GROW. Your support of our business is instrumental in helping us achieve our mission of ensuring cannabis medicines are made available to the hundreds of millions of patients who would have their lives improved by them.Â
The Seedrs fundraising round didn’t work out this time due to the changing needs of the business. However, I would like to say a huge thank you to each and every one of our Seedrs community for your support and the belief that you’ve shown in GROW and in our mission.Â
WHAT THIS MEANS FOR YOUR INVESTMENTÂ Â
While your original investment in us through Seedrs will be immediately returned to your Investor Account, there remains an opportunity to invest in GROW at this time and ahead of our planned IPO. This opportunity now includes the ability to benefit from EIS tax advantages, which we have reinstated following our review of our fundraising strategy. The Seedrs campaign was part of our overall fundraising strategy and fell within our series C. We have now raised over £4.5 million in direct investment through our Series C raise, which remains open, and overall, we have raised over £11 million to date. We would be delighted to hear from you if you would like to invest in GROW directly.Â
WHAT SHOULD I DO IF I STILL WANT TO INVEST IN GROW? Â
If you’d like to invest your original stake (and/or additional funds) back into GROW directly, please contact Hannah Nommé at hannah.nomme@growbiotech.com for advice on how to do this. Further information can also be found in our FAQs here.Â
OUR COMMITMENT TO YOU
We would like to reassure you that we remain committed to building the community and are focused on leading the way in providing global access to quality cannabis-based medicines to everyone who needs them. We welcome any enquiries you may have and thank you once again for your support.Â
Kind regards,Â
Ben LangleyÂ
CEO, GROW Group PLCÂ
* This is not an email invitation for investing, please seek guidance and advice on all inquiries to invest in unlisted companies via a regulated professional. To inquire please ensure you review the status for qualifying investors. To invest in an unlisted company, you must qualify as a High-Networth Individual or Sophisticated Investor, please review definitions via the link here:Â https://help.seedrs.com/en/articles/5411669-self-certification-and-investor-profiles-explained